These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38504093)

  • 1. IFNα induces CCR5 in CD4
    Le Buanec H; Schiavon V; Merandet M; How-Kit A; Song H; Bergerat D; Fombellida-Lopez C; Bensussan A; Bouaziz JD; Burny A; Darcis G; Sajadi MM; Kottilil S; Zagury D; Gallo RC
    Commun Med (Lond); 2024 Mar; 4(1):52. PubMed ID: 38504093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early elevated IFNα is a key mediator of HIV pathogenesis.
    Buanec HL; Schiavon V; Merandet M; How-Kit A; Bergerat D; Fombellida-Lopez C; Bensussan A; Bouaziz JD; Burny A; Darcis G; Song H; Sajadi MM; Kottilil S; Gallo RC; Zagury D
    Commun Med (Lond); 2024 Mar; 4(1):53. PubMed ID: 38504106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNα induces CCR5 in CD4
    Le Buanec H; Schiavon V; Merandet M; How-Kit A; Song H; Bergerat D; Fombellida-Lopez C; Bensussan A; Bouaziz JD; Burny A; Darcis G; Sajadi MM; Kottilil S; Zagury D; Gallo RC
    Res Sq; 2023 May; ():. PubMed ID: 37214795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication
    Jacobs ES; Keating SM; Abdel-Mohsen M; Gibb SL; Heitman JW; Inglis HC; Martin JN; Zhang J; Kaidarova Z; Deng X; Wu S; Anastos K; Crystal H; Villacres MC; Young M; Greenblatt RM; Landay AL; Gange SJ; Deeks SG; Golub ET; Pillai SK; Norris PJ
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Elevated IFNα Identified as the Key Mediator of HIV Pathogenesis and its low level a Hallmark of Elite Controllers.
    Le Buanec H; Schiavon V; Merandet M; How-Kit A; Bergerat D; Fombellida-Lopez C; Bensussan A; Bouaziz JD; Burny A; Darcis G; Song H; Sajadi MM; Kottilil S; Gallo RC; Zagury D
    Res Sq; 2023 May; ():. PubMed ID: 37215045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral Treatment for HIV Elite Controllers?
    Ruiz-Mateos E; Poveda E; Lederman MM
    Pathog Immun; 2020; 5(1):121-133. PubMed ID: 32582872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposable elements may enhance antiviral resistance in HIV-1 elite controllers.
    Singh M; Leddy SM; Iñiguez LP; Bendall ML; Nixon DF; Feschotte C
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression.
    Sugawara S; Reeves RK; Jost S
    Front Immunol; 2022; 13():858383. PubMed ID: 35572502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
    Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
    J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmatic Levels of IL-18, IP-10, and Activated CD8
    Côrtes FH; de Paula HHS; Bello G; Ribeiro-Alves M; de Azevedo SSD; Caetano DG; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Front Immunol; 2018; 9():1576. PubMed ID: 30050532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.
    Casado C; Marrero-Hernández S; Márquez-Arce D; Pernas M; Marfil S; Borràs-Grañana F; Olivares I; Cabrera-Rodríguez R; Valera MS; de Armas-Rillo L; Lemey P; Blanco J; Valenzuela-Fernández A; Lopez-Galíndez C
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Front Immunol; 2020; 11():583820. PubMed ID: 33101312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
    García M; López-Fernández L; Mínguez P; Morón-López S; Restrepo C; Navarrete-Muñoz MA; López-Bernaldo JC; Benguría A; García MI; Cabello A; Fernández-Guerrero M; De la Hera FJ; Estrada V; Barros C; Martínez-Picado J; Górgolas M; Benito JM; Rallón N
    J Mol Med (Berl); 2020 Aug; 98(8):1093-1105. PubMed ID: 32556382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elite controllers long-term non progressors present improved survival and slower disease progression.
    Capa L; Ayala-Suárez R; De La Torre Tarazona HE; González-García J; Del Romero J; Alcamí J; Díez-Fuertes F
    Sci Rep; 2022 Sep; 12(1):16356. PubMed ID: 36175445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART.
    Ujeneza EL; Ndifon W; Sawry S; Fatti G; Riou J; Davies MA; Nieuwoudt M;
    Elife; 2021 Jan; 10():. PubMed ID: 33443013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.